Prognostic Implications for High Expression of MiR-25 in Lung Adenocarcinomas of Female Non-smokers

• Published in: Asian Pacific journal of cancer prevention : APJCP 2014, Vol.15 (3), p.1197-1203
• Main Authors: Xu, Fang-Xiu, Su, Yu-Liang, Zhang, Huan, Kong, Jin-Yu, Yu, Herbert, Qian, Bi-Yun
• Format: Article
• Language: Korean
• ISSN: 1513-7368; 2476-762X

Background: Adenocarcinoma (ADC) is the most common histological type of lung cancer and its proportion is rising, especially in Asian non-smoking women. Recent studies suggest miR-25 may have diverse effects on the pathogenesis of different types of cancer. However, the role of miR-25 in lung cancer is still unknown. The aim of this study was to investigate the potential clinical value of miR-25 in non-smoking women with lung ADC. Patients and Methods: Quantitative RT-PCR was performed to evaluate the expression of miR-25 in 100 lung ADC tumor tissues and matched plasma samples and Pearson correlation tests were used to analyze the relationship between values. Associations of miR-25 expression with clinicopathological features were determined using the Student's t-test. To determine prognostic value, overall survival (OS) was evaluated using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazard model. Results: Expression of miR-25 in tissue was found to be associated with lymph node metastasis (P=0.021) and disease stage (P=0.012). Moreover, high miR-25 expression was also associated with poorer overall survival of women with lung ADC (P=0.008). Conclusion: Tissue miR-25 expression may be associated with tumor progression and have prognostic implications in female lung ADC patients.